MedPath

ESSILOR-POLYLITE TAIWAN CO., LTD.

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Stellest Lenses and Low-concentration Atropine Myopia Control Among Children

Not Applicable
Recruiting
Conditions
Myopia
Interventions
Combination Product: Stellest Lenses+0.05% atropine
Device: Stellest Lenses
Drug: Single vision Lenses+0.05% atropine
First Posted Date
2024-04-03
Last Posted Date
2024-04-04
Lead Sponsor
Essilor-Polylite Taiwan Co., Ltd.
Target Recruit Count
100
Registration Number
NCT06344429
Locations
🇨🇳

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan

News

No news found
© Copyright 2025. All Rights Reserved by MedPath